ArticleNanomaterials (Basel, Switzerland)2019

Paclitaxel-Trastuzumab Mixed Nanovehicle to Target HER2-Overexpressing Tumors.

Celia Nieto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.